SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001157523-12-000122
Filing Date
2012-01-12
Accepted
2012-01-12 17:13:58
Documents
7
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 TARO PHARMACEUTICAL INDUSTRIES LTD. 20-F/A a50130473.htm 20-F/A 1878192
2 EXHIBIT 12.1 a50130473_ex121.htm EX-12.1 16104
3 EXHIBIT 12.2 a50130473_ex122.htm EX-12.2 15311
4 EXHIBIT 13 a50130473_ex13.htm EX-13 10267
5 LOGO eylogo.jpg GRAPHIC 3806
6 GRAPHIC graphic1.jpg GRAPHIC 7421
7 GRAPHIC graphic2.jpg GRAPHIC 14207
  Complete submission text file 0001157523-12-000122.txt   1956381
Mailing Address THREE SKYLINE DR HAWTHORNE NY 10532
Business Address 14 HAKTOR ST HAIFA BAY L3 26110 9143459001
TARO PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000906338 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 000-22286 | Film No.: 12524793
SIC: 2834 Pharmaceutical Preparations